Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.
about
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Targeting Malignant Brain Tumors with Antibodies.Antiviral Immunotoxin Against Bovine herpesvirus-1: Targeted Inhibition of Viral Replication and Apoptosis of Infected Cell.
P2860
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Production and quality control ...... r a phase I/II clinical trial.
@en
type
label
Production and quality control ...... r a phase I/II clinical trial.
@en
prefLabel
Production and quality control ...... r a phase I/II clinical trial.
@en
P2093
P2860
P921
P1476
Production and quality control ...... r a phase I/II clinical trial.
@en
P2093
Charles N Pegram
Chien-Tsun Kuan
Hailan Piao
Ira H Pastan
Scott E Szafranski
Vidyalakshmi Chandramohan
P2860
P2888
P304
P356
10.1007/S00253-016-8063-X
P407
P577
2016-12-24T00:00:00Z
P6179
1023374600